Insider Trading Arrangements [Line Items] Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] Accounts receivable Accounts receivable, net Accumulated amortization Less: accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Additional paid-in capital Additional Paid in Capital Amortization of intangible assets Amortization of intangible assets Impairment of Long-lived Assets [Abstract] Construction in Process [Member] CONDENSED CONSOLIDATED BALANCE SHEETS [Abstract] BASIC EARNINGS (LOSS) PER COMMON SHARE (in dollars per share) Basic earnings per common shares (in dollars per share) Basic earnings per share (in dollars per share) Amortization of debt discount Building [Member] Cash and cash equivalents Cash and cash equivalents Cash paid for interest Interest Paid, Excluding Capitalized Interest, Operating Activities Accounts receivable Increase (Decrease) in Accounts Receivable Change in Accounting Estimate by Type [Axis] Change in Accounting Estimate, Type [Domain] Change in Accounting Estimate [Line Items] Change in Accounting Estimate [Table] Inventories Increase (Decrease) in Inventories Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Changes in operating assets and liabilities: Accounts payable Increase (Decrease) in Accounts Payable Accrued expenses COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] Common stock, shares authorized (in shares) Common stock, shares authorized (in shares) Common stock, shares issued (in shares) Common stock, shares outstanding (in shares) Common stock, shares outstanding (in shares) Common Stock - voting, $0.0001 par value, 300,000,000 shares authorized,236,378,607 and 226,063,032 shares issued and outstanding at September 30, 2024 and December 31, 2023 Common Stock, Value, Issued Stock-based compensation expense [Abstract] Internally Developed Software [Member] Computer Software, Intangible Asset [Member] Concentration Risk Type [Axis] Concentration Risk [Line Items] Concentration Risk [Table] Concentration Risk Type [Domain] Cost of product revenue Cost of product revenue Cost of Revenue Cost of Product Revenue Current liabilities Total current liabilities Liabilities, Current Current liabilities: Customer Concentration Risk [Member] Outstanding principal amount Incurred fees and expenses Frequency of periodic payment Effective interest rate Interest rate Maturity date Debt Instrument, Name [Domain] Interest payments Scheduled principal payments Less: Debt discount Debt Instrument, Unamortized Discount Debt Instruments [Abstract] Debt Instrument [Axis] Debt Instrument [Line Items] Schedule of Long-term Debt Instruments [Table] Deferred revenue, net of current portion Depreciation and amortization expense Depreciation and amortization DILUTED EARNINGS (LOSS) PER COMMON SHARE (in dollars per share) Diluted earnings per common share (in dollars per share) Diluted earnings per share (in dollars per share) Effective tax rate Federal statutory tax rate Stock-based compensation Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Stock-based Compensation [Abstract] Fair Value of Financial Instruments Finite-Lived Intangible Assets, Major Class Name [Domain] Finite Lived Intangible Assets By Major Class Axis Finite-Lived Intangible Assets [Line Items] Estimated Aggregate Amortization Expense [Abstract] Furniture and Fixtures [Member] Loss on disposal of fixed assets Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property Goodwill Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Gross profit Gross Profit Impairment of long-lived assets Impairment, Long-Lived Asset, Held-for-Use Impairment charges related to goodwill Goodwill, Impairment Loss CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS [Abstract] INCOME TAXES Income Tax Disclosure [Text Block] Income Taxes Income Tax, Policy [Policy Text Block] Intangible assets, net Cost Net Finite-Lived Intangible Assets, Net [Abstract] Goodwill Goodwill Finished goods Inventories Total inventories Inventory, Net Raw materials Work-in-process Inventories Inventory, Policy [Policy Text Block] Land [Member] Leasehold Improvements [Member] TOTAL LIABILITIES Liabilities TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities and Equity LIABILITIES AND STOCKHOLDERS' EQUITY Aggregate principal amount revolving credit facility Contingencies [Line Items] Loss Contingencies [Table] Manufacturing and Laboratory Equipment [Member] Related and Nonrelated Parties [Axis] Net cash used in financing activities Net Cash Provided by (Used in) Financing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net cash used in investing activities Net Cash Provided by (Used in) Investing Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net cash provided by (used in) operating activities Net Cash Provided by (Used in) Operating Activities CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) NET INCOME (LOSS) Net income available to common stockholders (numerator) Net income Interest and other (expense) income, net Other expense, net OTHER INCOME (EXPENSE): Senior Notes Payable [Abstract] Office Equipment and Computer Software [Member] Net operating loss carryforwards Income (loss) from operations INCOME FROM OPERATIONS Income from operations ORGANIZATION AND BUSINESS Other expense Preferred stock, shares authorized (in shares) Preferred Stock, Capital Shares Reserved for Future Issuance Preferred stock, shares authorized (in shares) Preferred stock, shares issued (in shares) Preferred stock, outstanding (in shares) Preferred stock, shares outstanding (in shares) Preferred stock, par value (in dollars per share) Preferred stock, par value (in dollars per share) Proceeds from issuance of common stock Organization and Business [Abstract] Proceeds from Issuance or Sale of Equity [Abstract] Net proceeds from the exercise of stock options Aggregate exercise proceeds Property, plant and equipment, gross Property and equipment, net Total property, plant and equipment, net PROPERTY AND EQUIPMENT [Abstract] Uncertain tax positions Acquisition of intangible assets Payments to Acquire Intangible Assets Purchase of property and equipment Payments to Acquire Property, Plant, and Equipment Accounts Receivable Receivable [Policy Text Block] Related and Nonrelated Parties [Domain] Related Party Transaction [Line Items] RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] Schedule of Related Party Transactions, by Related Party [Table] Repayment of revolving credit facility Repayment of notes payable Repayments of Notes Payable Research and Development [Member] Research Tax Credit Carryforward [Member] Accumulated deficit Retained Earnings (Accumulated Deficit) Revenue Recognition INVENTORIES Property and Equipment Property, Plant and Equipment [Table Text Block] SEGMENTS Summarized Financial Information Concerning Reportable Segments Segment Reporting Information [Line Items] Schedule of Segment Reporting Information, by Segment [Table] Selling, general and administrative Senior notes payable, net of discount Senior notes payable Forfeited (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Granted (in shares) Granted (in shares) Granted (in dollars per share) Granted (in dollars per share) Ending balance (in shares) Beginning balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Number Ending balance (in dollars per share) Beginning balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Vested (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Vested in Period Vested (in dollars per share) Options exercisable (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Number Options exercisable (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Dividend yield Volatility Risk-free interest rate Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Award Type [Domain] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES State [Member] CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS [Abstract] CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS EQUITY [Abstract] Stock-Based Compensation Share-Based Payment Arrangement [Policy Text Block] STOCKHOLDERS' EQUITY STOCKHOLDERS' EQUITY Equity, Attributable to Parent [Abstract] Warrants outstanding (in shares) Warrants outstanding (in shares) STOCKHOLDERS' EQUITY Warrant to purchase shares of common stock (in shares) SUPPLEMENTAL CASH FLOW INFORMATION [Abstract] Tax credit carryforwards Tax Credit Carryforward, Name [Domain] Tax Credit Carryforward [Axis] Cash paid for income taxes Total current assets Assets, Current Current assets: Unrecognized tax benefits Warrants [Member] Warrant [Member] Total shares - diluted (denominator) (in shares) Diluted (in shares) Potential shares of common stock arising from outstanding stock options, warrants and unvested RSUs (in shares) Weighted-average number of common shares (denominator) (in shares) Basic (in shares) Common Stock [Member] PROPERTY AND EQUIPMENT Long-Lived Tangible Asset [Domain] Buildings and Building Improvements [Member] Property, Plant and Equipment [Abstract] Research and development Research and Development Expense Total assets TOTAL ASSETS Accounts Receivable [Abstract] INTANGIBLE ASSETS Interest income Other non-current liabilities Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Income Tax Jurisdiction [Domain] Segment Reporting Information [Abstract] Statement [Table] Antidilutive Securities, Name [Domain] ASSETS Assets [Abstract] Statement [Line Items] Warrants Outstanding Class of Warrant or Right [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] STOCKHOLDERS' EQUITY [Abstract] Class of Warrant or Right [Line Items] SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION Federal [Member] Increase (Decrease) in Stockholders' Equity [Roll Forward] Warrants issued in connection with note payable Plasma center operating expenses Total operating expenses Operating Expenses Potentially dilutive securities (in shares) Antidilutive Securities [Axis] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Earnings/loss Per Common Share [Abstract] Calculation of Diluted Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Antidilutive Security, Excluded EPS Calculation [Table] Earnings/Loss Per Common Share Earnings Per Share, Policy [Policy Text Block] Loss Per Common Share [Abstract] Other current and non-current liabilities Property, Plant and Equipment [Table] Common stock, par value (in dollars per share) Common stock, par value (in dollars per share) Long-Lived Tangible Asset [Axis] Property, Plant and Equipment [Line Items] Common stock, available for issuance (in shares) Rent expense Balance Balance TOTAL STOCKHOLDERS' EQUITY Equity, Attributable to Parent Income tax expense Provision for income taxes Preferred Stock, $0.0001 par value, 10,000,000 shares authorized, no shares issued and outstanding Common Stock [Abstract] Preferred Stock [Abstract] Accounts Receivable [Member] Equity Components [Axis] Additional Paid-in Capital [Member] Accumulated Deficit [Member] Equity Component [Domain] Stock Options [Member] Interest paid in kind DEBT Exercise of stock options Exercise of stock options (in shares) Common stock shares issued (in shares) Segments [Axis] OPERATING EXPENSES: Unvested RSU, Shares [Abstract] Warrants Outstanding [Abstract] Stock Options, Vested and Expected to Vest [Abstract] Options outstanding, vested and expected to vest, ending balance (in dollars per share) Options outstanding, vested and expected to vest, beginning balance (in dollars per share) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Options outstanding, vested and expected to vest, beginning balance (in shares) Options outstanding, vested and expected to vest, ending balance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Fair Value Assumptions and Methodology [Abstract] WEIGHTED AVERAGE COMMON SHARES OUTSTANDING: Depreciation expense Depreciation, Depletion and Amortization LEASE OBLIGATIONS [Abstract] COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Accounts payable Accrued incentives Accrued distribution fees Accrued payroll and other compensation Accrued interest Other INCOME (LOSS) BEFORE INCOME TAXES Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Prepaid expenses and other current assets Segments [Domain] Operating Segments [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Goodwill [Abstract] Goodwill, Impaired, Accumulated Impairment Loss [Abstract] Shares withheld to cover portion of tax liabilities (in shares) Share-Based Payment Arrangement, Shares Withheld for Tax Withholding Obligation ACCRUED EXPENSES AND OTHER CURRENT LIABILITIES [Abstract] ORGANIZATION AND BUSINESS [Abstract] Balance (in shares) Balance (in shares) Shares, Outstanding Accrued Expenses and Other Current Liabilities Schedule of Accrued Liabilities [Table Text Block] Components of Inventory COMMITMENTS AND CONTINGENCIES [Abstract] INCOME TAXES [Abstract] Income Taxes [Abstract] INTANGIBLE ASSETS [Abstract] Supplemental Cash Flow Information INVENTORIES [Abstract] DEBT [Abstract] Schedule of Stock-Based Compensation Expense Schedule of Option Activity Schedule of Assumptions Stock-based compensation APIC, Share-Based Payment Arrangement, Option, Increase for Cost Recognition Use of Estimates Revolving facility percentage Summary of Outstanding Senior Notes Payable RSUs [Member] Restricted Stock Units (RSUs) [Member] Restricted Stock Units [Member] Intangible Asset Future Aggregate Amortization Expense Research and Development [Member] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES [Abstract] SEGMENTS [Abstract] RELATED PARTY TRANSACTIONS [Abstract] SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION [Abstract] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Income Tax Jurisdiction [Axis] Number of stock options granted (in shares) Noncash Financing and Investing Activities [Abstract] Calculation of Basic and Diluted Earnings Per Share Basis of Presentation Purchased materials amount Related Party Transaction, Purchases from Related Party Schedule of Intangible Assets Schedule of Indefinite-Lived Intangible Assets [Table Text Block] Intangible Asset, Finite-Lived [Table] Cost of programs during the period Number of restricted stock units granted (in shares) Unvested RSU, Weighted Average Grant Date Fair Value [Abstract] Warrants Outstanding, Weighted Average Grant Date Fair Value [Abstract] Forfeited (in dollars per share) Unrecognized compensation expense, stock options Unrecognized compensation expense, non option Impairment of Long-Lived Assets Plan Name [Axis] Plan Name [Domain] Award Type [Axis] Statement of Income Location, Balance [Axis] Statement of Income Location, Balance [Domain] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] Accrued Expenses and Other Current Liabilities [Abstract] Accrued Liabilities and Other Liabilities [Abstract] Accrued expenses and other current liabilities Accrual adjustments Total accrued expenses and other current liabilities Accrual adjustments Revolving Credit Facility [Member] Credit Facility [Axis] Credit Facility [Domain] Estimated useful life Property, Plant and Equipment, Useful Life 2024 Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year 2025 2026 Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Two 2027 Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Three 2028 Finite-Lived Intangible Assets, Amortization Expense, Rolling Year Four Weighted average remaining contractual life of stock options, outstanding Weighted average remaining contractual life of stock options, expected to vest Expected term Equity incentive plans, term Share-Based Compensation Arrangement by Share-Based Payment Award, Award Requisite Service Period Equity incentive plans, vesting period Restricted stock units vested over a period Unrecognized compensation expense recognition period Corporate [Member] Corporate Segment [Member] Number of operating segments Selling, General and Administrative [Member] Percentage of account receivables Percentage of consolidated revenues Schedule of Unvested RSU Activity Cost of Product Revenue [Member] Plasma Center Operating Expenses [Member] Net operating loss carryforwards, expiration Net Revenues According to Geographic Area Debt Instrument, Redemption, Period [Axis] Debt Instrument, Redemption, Period [Domain] Amortization period Finite-Lived Intangible Assets, Remaining Amortization Period Increase applicable margin Percentage of prepaid principal amount Tax Period [Axis] Tax Period [Domain] Warrant exercise price per share (in dollars per share) International [Member] Revenue Recognition [Abstract] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items] Current portion of deferred revenue Right-to-use assets Payments Under Lease Obligations [Abstract] Revenues REVENUES Revenue from Contract with Customer, Excluding Assessed Tax Revenue from Contract with Customer Benchmark [Member] Net increase (decrease) in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents - beginning of period Cash and cash equivalents - end of period Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash payments for lease Operating Lease, Payments Payments on finance lease obligations Finance Lease, Principal Payments Total payments Lessee, Operating Lease, Liability, to be Paid Thereafter Year ended December 31, 2025 Lessee, Operating Lease, Liability, to be Paid, Year One 2029 2028 2027 Lessee, Operating Lease, Liability, to be Paid, Year Three 2026 Lessee, Operating Lease, Liability, to be Paid, Year Two Remainder of 2024 Payments Under Lease Obligations Aggregate lease expense Operating Lease, Expense Current portion of lease obligations Current portion Less: imputed interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Lease obligations, net of current portion Balance at September 30, 2024 LEASE OBLIGATIONS Weighted average remaining term Revenues [Member] Revenue from Contract with Customer, Product and Service Benchmark [Member] Capital expenditures Related Party [Member] Debt Instrument, Variable Interest Rate, Type [Extensible Enumeration] Interest expense Interest Expense, Nonoperating Title and Position [Domain] Customer [Domain] Directors [Member] Director [Member] Executive Officer [Member] Geographical [Domain] Geographical [Axis] Customer [Axis] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Minimum [Member] Counterparty Name [Axis] Counterparty Name [Domain] Title and Position [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Product and Service [Domain] Product and Service [Axis] United States [Member] Cover [Abstract] Document Type Document Quarterly Report Document Transition Report Entity Interactive Data Current Amendment Flag Document Fiscal Year Focus Document Fiscal Period Focus Document Period End Date Entity Registrant Name Entity Central Index Key Entity File Number Entity Tax Identification Number Entity Incorporation, State or Country Code Current Fiscal Year End Date Entity Current Reporting Status Entity Shell Company Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Common Stock, Shares Outstanding Amount of noncash revenue related to amortization of license revenue. Amortization of License Revenue Amortization of license revenue Amount of cash outflow related to taxes on vested Restricted Stock Units. Taxes Paid on Vested Restricted Stock Units Taxes paid on vested Restricted Stock Units Amount of increase (decrease) in deposits and operating assets classified as other. Increase (Decrease) in Deposits and Other Assets Deposits and other assets Net Operating Loss Carryforwards [Abstract] Net Operating Losses [Abstract] Operating loss carryforwards are subject to limitation as a result of the ownership change. Operating Loss Carryforwards Subject to Limitation Ownership Changes Operating loss carryforwards subject to limitation ownership changes Identified as tax years 2028 through 2043. Tax Year 2028 through 2043 [Member] 2028 through 2043 [Member] Aggregate change in value for stock issued during the period as a result of the cashless exercise of warrants. Stock Issued During Period Value Cashless Exercise Of Warrants Cashless exercise of warrants Number of shares issued during the period as a result of the cashless exercise of warrants. Stock Issued During Period Shares Cashless Exercise Of Warrants Cashless exercise of warrants (in shares) Value of stock related to restricted stock awards issued during the period, net of shares withheld to cover grantees' income tax liability. Vesting of Restricted Stock Units Net of Shares Withheld for Taxes, Amount Vesting of Restricted Stock Units, net of shares withheld for taxes Number of shares issued during the period related to restricted stock awards, net of shares withheld to cover grantees' income tax liability. Vesting of Restricted Stock Units Net of Shares Withheld for Taxes, Shares Vesting of Restricted Stock Units, net of shares withheld for taxes (in shares) Present value of lessee's discounted obligation for lease payments from operating and finance leases. Operating and Financing Lease, Liability Operating and financing lease liabilities Number of plasma collection facilities having FDA license. Number of FDA-Licensed Plasma Collection Facilities Number of FDA-licensed plasma collection facilities Component of Plasma Collection Centers segment that usually provides financial, operational and administrative support and is considered an operating segment. Plasma Collection Centers Segment [Member] Plasma Collection Centers [Member] Component of ADMA BioManufacturing that usually provides financial, operational and administrative support and is considered an operating segment. ADMA BioManufacturing Segment [Member] ADMA BioManufacturing [Member] Entity's established relationships with its customers through contracts. Trademark and Other Intangible Rights Related to Nabi-HB [Member] Trademark and Other Intangible Rights Related to Nabi-HB [Member] Entity's established relationships with its customers through contracts. Right to Intermediates [Member] Rights to Intermediates [Member] Principal balance of the loans and any other obligations advanced or otherwise owed. Long Term Liability, End of Term Fee Payable End of term fee Carrying value of amounts transferred to third parties for security purposes that are expected to be returned or applied towards payment after one year or beyond the operating cycle, if longer and amount of noncurrent assets classified as other. Deposits and Other Noncurrent Assets Deposits and other assets Unvested share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met. Unvested Restricted Stock Units RSU [Member] Unvested Restricted Stock Units [Member] Number of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would have been antidilutive for the period presented. Potentially dilutive securities not included in computation of diluted net loss per share (in shares) Potentially dilutive securities not included in computation of diluted loss per share amount (in shares) Use of Estimates [Abstract] Use of Estimates [Abstract] Accrual for U.S. Medicaid Rebates. Accrual for U.S. Medicaid Rebates [Member] Accrual for U.S. Medicaid Rebates [Member] Carrying value as of the balance sheet date of obligations incurred through that date and payable for testing. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Testing, Current Accrued testing Carrying value as of the balance sheet date of rebates for Medicaid or other third parties related to sale of product. Accrued Rebates, Current Accrued rebates Related Party Transaction [Abstract] Related Party Transactions [Abstract] The number of executive officers who have exercised options to purchase shares. Number of Executive Officers that Exercised Options Number of executive officers that exercised options Number of shares purchased in cashless exercise for issuance under share-based payment arrangement. Share Based Compensation Arrangement By Share Based Payment Award, Shares Purchased in Cashless Transaction for Award Shares purchased in cashless transaction (in shares) Name of the entity associated with related party. Areth, LLC [Member] Name of the entity associated with related party. GenesisBPS [Member] Genesis [Member] Amount of equipment acquired in a noncash (or part noncash) acquisition and reflected in accounts payable and accrued liabilities. Equipment Acquired Reflected in Accounts Payable and Accrued Liabilities Equipment acquired reflected in accounts payable and accrued liabilities Amount of warrants issued in connection with the issuance of notes payable. Warrants Issued in Connection with Notes Payable Warrants Issued in connection with notes payable A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars. Term Loan [Member] Term Loan [Member] Arrangement in which facility proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount. Hayfin Credit Facility [Member] Arrangement in which facility proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount. Ares Credit Facility [Member] Ares Credit Facility [Member] Amount of expenses associated with exit fee of debt instrument. Debt Instrument, Exit Fee Exit fee Amount represent the original discount payable in related transaction in credit facility. Original Discount Payable, Credit Facility Original discount payable Term of the interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Debt Instrument, Term of Variable Rate Term of variable rate Amount represents the payments of premium. Prepayments of Debt Premium Prepayments of premium Percentage points added to the reference rate to compute the margin rate on the debt instrument. Debt Instrument Applicable Margin Applicable margin The percentage of credit facility from a contractual arrangement with the lender repaid. Percentage of Credit Facility Repaid Percentage of credit facility repaid Number of business days for prior written notice to pay outstanding principal loans, Number of business days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of Business Days for Prior Written Notice to Prepay Outstanding Principal Number of business days for prior written notice The carrying amount of minimum liquidity requirements required to be maintained by the borrower per the Company's credit facilities covenants under the loan agreement that are not restricted as to withdrawal or usage. Minimum Liquidity Covenants, Credit Facilities Minimum liquidity covenant Number of business days, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Number of Business Days Number of business days Ares credit agreement is a legally-binding contract documenting the terms of a loan agreement; it is made between a person or party borrowing money and a lender. Ares Credit Agreement [Member] Ares Credit Agreement [Member] Carrying value as of the balance sheet date of Notes with the highest claim on the assets of the issuer in case of bankruptcy or liquidation (with maturities initially due after one year or beyond the operating cycle if longer), excluding debt discount and current portion. Senior Notes Payable Before Debt Discount Senior notes payable before debt discount The third anniversary representing most current period of debt redemption features under terms of the debt agreement. Prepaid on or Prior to Third Anniversary [Member] Prepaid on or Prior to Third Anniversary [Member] The first anniversary representing most prepaid of after period of debt redemption features under terms of the debt agreement. Prepaid after the First Anniversary [Member] The second anniversary representing most current period of debt redemption features under terms of the debt agreement. Prepaid on or Prior to Second Anniversary [Member] Prepaid on or Prior to Second Anniversary [Member] The first anniversary representing most current period of debt redemption features under terms of the debt agreement. Prepaid on or Prior to First Anniversary [Member] Information about number of customers accounting for a percentage of consolidated revenues. Four Customers [Member] Four Customers [Member] Information about number of customers accounting for a percentage of consolidated revenues. Five Customers [Member] Five Customers [Member] Amount of allowance for contractual credits and doubtful accounts. Accounts Receivable, Allowance for Contractual Credits and Doubtful Accounts Accounts receivable, allowances for contractual credits and credit losses Number of major customers of the organization. Number of Customers Number of customers Number of customers The amount of difference between current assets and liabilities. Working Capital Working capital Number of products approved by FDA. Number of FDA Approved Product Number of FDA approved product Number of plasma collection facilities under various stages of development. Number of Plasma Collection Facilities Under Development Number of plasma collection facilities under approval and development Vendor and Licensor Commitments [Abstract] Vendor and Licensor Commitments [Abstract] Number of wholly-owned plasma collection facilities of the entity. Number of Plasma Collection Facilities Number of plasma collection facilities Post-Marketing Commitments [Abstract] Number of renewal terms to extend purchase agreement, if agreed to by the parties. Number of Renewal Terms Number of renewal terms Plasma supply agreement term period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Plasma supply agreement term Plasma supply agreement term ASCENIV an Intravenous Immune Globulin ("IVIG") product indicated for the treatment of Primary Humoral Immunodeficiency ("PI"), also known as Primary Immunodeficiency Disease ("PIDD"). ASCENIV [Member] Plasma purchase agreement to purchase plasma containing antibodies to RSV to be used in the manufacture of ASCENIV. Plasma Purchase Agreement One [Member] 2011 Plasma Purchase Agreement [Member] Plasma purchase agreement renewal period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Plasma Purchase Agreement Renewal Period Plasma purchase agreement renewal period Information about number of customers accounting for a percentage of consolidated revenues. Two Customers [Member] Name of license agreement. Biotest License Agreement [Member] Remaining amortization period of deferred revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Amortization period Stock Options [Abstract] Stock Options, Weighted Average Exercise Price [Abstract] Stock Options, Weighted Average Exercise Price [Abstract] The number of shares withheld by the Company to cover aggregate exercise prices under share-based payment arrangement. Share-based Compensation Arrangement by Share-based Payment Award, Options, Shares Withheld to Cover Aggregate Exercise Prices Shares withheld to cover aggregate exercise prices (in shares) Weighted-average exercise price, for fully vested and expected to vest that were not exercised or put into effect as a result of the occurrence of a terminating event. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Forfeited, Weighted Average Exercise Price Forfeited (in dollars per share) Stock Option, Shares [Abstract] Stock Options, Shares [Abstract] Number of shares under fully vested and expected to vest options for which rights to exercise lapsed. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Expired, Number Expired (in shares) A group of person working with the entity. Employees [Member] Employees [Member] Number of shares under fully vested and expected to vest options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Forfeited, Number Forfeited (in shares) Weighted-average exercise price, for fully vested and expected to vest that were expired. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Expired, Weighted Average Exercise Price Expired (in dollars per share) Equity compensation is often a significant portion of the total compensation paid to employees and other service providers. Equity Incentive Plans [Member] Equity Incentive Plans [Member] Number of shares under fully vested and expected to vest options that were exercised during the current period. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercised, Number Exercised (in shares) Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest granted. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Granted, Weighted Average Exercise Price Granted (in dollars per share) Restricted Stock Units [Abstract] The number of shares withheld by the Company to cover employees' tax liabilities under share-based payment arrangement. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Shares Withheld for Employees Tax Liabilities Shares withheld for tax withholding obligation (in shares) Number of shares under fully vested and expected to vest options that were granted during the current period. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Granted, Number Granted (in shares) Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercised. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercised, Weighted Average Exercise Price Exercised (in dollars per share) The shares value withheld by the Company to cover employees' tax liabilities under share-based payment arrangement. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Shares Value Withheld for Employees Tax Liabilities Amount of shares withheld for tax withholding obligation Represents 2022 compensation plan of equity based compensation arrangement plan. Two022 Compensation Plan [Member] 2022 Compensation Plan [Member] The number of equity-based payment instruments, excluding stock (or unit) options, that expired during the reporting period. Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Expired in Period Expired (in shares) The number of equity-based payment instruments, excluding stock (or unit) options, that exercised during the reporting period. Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other than Options Exercised in Period Exercised (in shares) The weighted average fair value at expired date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Expired in Period Weighted Average Grant Date Fair Value Expired (in dollars per share) The weighted average fair value at exercised date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Share Based Compensation Arrangement by Share Based Payment Award Equity Instruments Other Than Options Exercised in Period Weighted Average Grant Date Fair Value Exercised (in dollars per share) On the hayfin closing date, the Company issued the hayfin warrant. Hayfin Warrants [Member] Warrants [Abstract] Warrants [Abstract]